Park Avenue Securities’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,119
Closed -$250K 1156
2022
Q1
$250K Buy
8,119
+342
+4% +$12.3K ﹤0.01% 1015
2021
Q4
$353K Sell
7,777
-42
-0.5% -$1.8K 0.01% 854
2021
Q3
$340K Buy
7,819
+717
+10% +$31.2K 0.01% 811
2021
Q2
$327K Buy
7,102
+1,182
+20% +$54.6K 0.01% 808
2021
Q1
$263K Buy
+5,920
New +$248K 0.01% 831

Other funds holding NEOG

Park Avenue Securities's NEOG Position: Q2 2022 in Review

Park Avenue Securities sold out of Neogen (NEOG) in Q2 2022, closing a stake of 8,119 shares — an estimated $250K sold.

Park Avenue Securities first reported a position in NEOG in Q1 2021 and held it in 5 quarters. The position peaked at $353K in Q4 2021. 309 funds tracked by Wall St. Rank hold NEOG as of Q2 2022.

  • Park Avenue Securities reported no remaining Neogen position as of Q2 2022 after selling out during the quarter.
  • Park Avenue Securities sold 8,119 Neogen shares in Q2 2022, an estimated $250K.
  • Park Avenue Securities first reported a position in Neogen in Q1 2021 and held it in 5 quarters.
  • Park Avenue Securities's Neogen position peaked at $353K in Q4 2021.
  • 309 funds tracked by Wall St. Rank held Neogen as of Q2 2022.

Based on Park Avenue Securities's 13F filing for Q2 2022, filed 27 Jul 2022.